A partir de cette page vous pouvez :
Retourner au premier écran avec les dernières notices... |
Descripteurs (mots clés)
Thésaurus Mesh
> S > Solutions ophtalmiques
Solutions ophtalmiques
Sterile solutions that are intended for instillation into the eye. It does not include solutions for cleaning eyeglasses or CONTACT LENS SOLUTIONS.
Synonyme(s)
CollyresRelation(s)
- voir aussi au terme générique : [Descripteurs (mots clés)] Solutions pharmaceutiques
- voir aussi au terme spécifique : [Descripteurs (mots clés)] Gouttes oculaires lubrifiantes
Ajouter le résultat dans votre panier Affiner la recherche
Etendre la recherche sur niveau(x) vers le bas
Approche pharmacologique de la presbytie [partie I] / Jean-Pierre Lagacé in L'optométriste (UNIQUEMENT ACCESSIBLE EN PDF), vol. 44, 03 (Mai-juin 2022)
[article]
in L'optométriste (UNIQUEMENT ACCESSIBLE EN PDF) > vol. 44, 03 (Mai-juin 2022)
Titre : Approche pharmacologique de la presbytie [partie I] Type de document : article de périodique Auteurs : Jean-Pierre Lagacé Année de publication : 2022 Langues : Français (fre) Descripteurs (mots clés) : [Thésaurus Mesh]:P:Presbytie:Presbytie / thérapie
[Thésaurus Mesh]:P:Presbytie:Presbytie / traitement médicamenteux
[Thésaurus Mesh]Phentolamine
[Thésaurus Mesh]Pilocarpine
[Thésaurus Mesh]Presbytie
[Thésaurus Mesh]Solutions ophtalmiques
[Thésaurus Mesh]Troubles de la visionRésumé : Dans le monde, on compte 1,8 milliard de presbytes, dont 826 millions sont malvoyants en raison d’une correction visuelle inadéquate. Bien que la plupart des Américains aient accès à une correction de la vision de près, nombre d’entre eux ne sont pas satisfaits de leur expérience de la presbytie ou des possibilités de la corriger. Permalink : https://bibliotheque.helb-prigogine.be/opac_css/index.php?lvl=notice_display&id= [article]Exemplaires
Cote Support Localisation Section Disponibilité aucun exemplaire Autologous Serum Eye Drops for Dry Eye: Systematic Review / Nicolas G. Quan in OVS : Optometry & Vision Science, vol. 100, 08 (Aout 2023)
[article]
in OVS : Optometry & Vision Science > vol. 100, 08 (Aout 2023)
Titre : Autologous Serum Eye Drops for Dry Eye: Systematic Review Type de document : article de périodique Auteurs : Nicolas G. Quan ; Louis Leslie ; Tianjing Li Année de publication : 2023 Langues : Français (fre) Descripteurs (mots clés) : [Thésaurus Mesh]:S:Syndromes de l'oeil sec:Syndromes de l'oeil sec / thérapie
[Thésaurus Mesh]Solutions ophtalmiques
[Thésaurus Mesh]Syndromes de l'oeil secMots-clés : examen systématique sérum autologue Résumé : BACKGROUND
Dry eye is a common condition with serious implications worldwide. The unique composition of autologous serum (AS) eye drops has been hypothesized as a possible treatment.
OBJECTIVES
This study aimed to review the effectiveness and safety of AS.
DATA SOURCES
We searched five databases and three registries up to September 30, 2022.
STUDY ELIGIBILITY
We included randomized controlled trials (RCTs) comparing AS with artificial tears, saline, or placebo for participants with dry eye.
STUDY APPRAISAL AND SYNTHESIS METHODS
We adhered to Cochrane methods for study selection, data extraction, risk-of-bias assessment, and synthesis. We used the Grading of Recommendations Assessment, Development and Evaluation framework to evaluate the certainty of evidence.
RESULTS
We included six RCTs with 116 participants. Four trials compared AS with artificial tears. We found low-certainty evidence that AS may improve symptoms (0- to 100-point pain scale) after 2 weeks of treatment compared with saline (mean difference, −12.00; 95% confidence interval, −20.16 to −3.84; 1 RCT, 20 participants). Ocular surface outcomes (corneal staining, conjunctival staining, tear breakup time, Schirmer test) were inconclusive. Two trials compared AS with saline. Very low-certainty evidence suggested that Rose Bengal staining (0- to 9-point scale) may be slightly improved after 4 weeks of treatment compared with saline (mean difference, −0.60; 95% confidence interval, −1.11 to −0.09; 35 eyes). None of the trials reported outcomes of corneal topography, conjunctival biopsy, quality of life, economic outcomes, or adverse events.
LIMITATIONS
We were unable to use all data because of unclear reporting.
CONCLUSIONS
The effectiveness of AS is uncertain based on current data. Symptoms improved slightly with AS compared with artificial tears for 2 weeks. Staining scores improved slightly with AS compared with saline, with no benefit identified for other measures.
IMPLICATIONS OF KEY FINDINGS
High-quality, large trials enrolling diverse participants with varying severity are needed. A core outcome set would allow for evidence-based treatment decisions consistent with current knowledge and patient values.Permalink : https://bibliotheque.helb-prigogine.be/opac_css/index.php?lvl=notice_display&id= [article]Exemplaires
Cote Support Localisation Section Disponibilité aucun exemplaire Case Report: Intracorneal Hemorrhages Seen with Scleral Contact Lens Wear and Netarsudil Therapy in OVS : Optometry & Vision Science, vol. 99, 04 (Avril 2022)
[article]
in OVS : Optometry & Vision Science > vol. 99, 04 (Avril 2022)
Titre : Case Report: Intracorneal Hemorrhages Seen with Scleral Contact Lens Wear and Netarsudil Therapy Type de document : article de périodique Année de publication : 2022 Langues : Français (fre) Descripteurs (mots clés) : [Thésaurus HELB]:Paramédical:Effets indésirables
[Thésaurus HELB]:Paramédical:Lentille sclérale /complications
[Thésaurus Mesh]Glaucome à angle ouvert
[Thésaurus Mesh]Solutions ophtalmiquesMots-clés : netarsudil hémorragies intracornéennes Résumé : SIGNIFICANCE: Intracorneal hemorrhages are a rare finding generally associated with surgery or trauma. There is
no consensus on preferred management except eliminating or addressing the causative mechanism in hopes of reducing the risk of corneal haze or scarring.
PURPOSE: This case highlights a rare adverse outcome of intracorneal hemorrhages occurring after recent initiation
of netarsudil, possibly exacerbated by scleral contact lens wear in a patient with open-angle glaucoma and limbal
stem cell deficiency.
CASE REPORT: A 77-year-old man using scleral contact lenses for therapeutic management of limbal stem cell
deficiency started netarsudil for open-angle glaucoma. During an annual follow-up to adjust his scleral contact
lenses, the patient developed peripheral intracorneal hemorrhages bilaterally. The intracorneal hemorrhages resolved over the course of 10 weeks after minor adjustments were made to the scleral contact lens fit and netasurdil
was discontinued. Visual acuity and intraocular pressure remained stable throughout.
CONCLUSIONS: There are few reports of intracorneal hemorrhages associated with scleral contact lens use and
even fewer associated with the use of netarsudil. This case proposes several possible causes of the intracorneal
hemorrhages, including topical rho-associated kinase inhibitors, contact lens wear, and trauma. Further studies are
needed to determine if netarsudil is associated with intracorneal hemorrhages, to understand the sequelae of
intracorneal hemorrhages in netarsudil therapy, and to recommend management when intracorneal hemorrhages
manifest with netarsudil usePermalink : https://bibliotheque.helb-prigogine.be/opac_css/index.php?lvl=notice_display&id= [article]Exemplaires
Cote Support Localisation Section Disponibilité aucun exemplaire Differential Antimicrobial Efficacy of Multipurpose Solutions against Acanthamoeba Trophozoites / Rhonda Walters in OVS : Optometry & Vision Science, vol. 98,12 (Décembre 2021)
[article]
in OVS : Optometry & Vision Science > vol. 98,12 (Décembre 2021)
Titre : Differential Antimicrobial Efficacy of Multipurpose Solutions against Acanthamoeba Trophozoites Type de document : article de périodique Auteurs : Rhonda Walters ; Allison Campolo ; Manal M. Gabriel ; Elise Miller ; Paul Shannon ; Cindy McAnall ; Monica Crary Année de publication : 2021 Langues : Français (fre) Descripteurs (mots clés) : [Thésaurus Mesh]:I:Infections virales de l'oeil:Infections virales de l'oeil / prévention et contrôle
[Thésaurus Mesh]:K:Kératite:Kératite / prévention et contrôle
[Thésaurus Mesh]Acanthamoeba castellanii
[Thésaurus Mesh]Hygiène
[Thésaurus Mesh]Lentilles de contact
[Thésaurus Mesh]Solutions ophtalmiques
[Thésaurus HELB]:Optique:port de lentilles de contactRésumé : SIGNIFICANCE
This investigation examines the effectiveness of several common contact lens solutions in the disinfection of Acanthamoeba, which causes a serious eye infection most often resulting from dysfunctional or improper use of contact lens products.
PURPOSE
Acanthamoeba keratitis is an eye infection caused by a free-living amoeba, which can lead to extensive corneal damage and frequently blindness. Acanthamoeba keratitis is linked with contact lens use combined with noncompliance with contact lens care cleaning regimens. The patient's choice and use of multipurpose solutions (MPSs) continue to be a risk factor for Acanthamoeba keratitis. Thus, it is critical that the Acanthamoeba disinfection efficacy of the popular MPSs be determined. Here we compare the efficacy of seven major MPSs on the global market.
METHODS
Using standard methods of Acanthamoeba disinfection and quantification, Acanthamoeba ATCC 30461, 30868, 50370, and 50676 trophozoites were inoculated into each MPS and held for the manufacturer's recommended disinfection time. Acanthamoeba recovery plates were incubated for 14 days, after which positive wells were identified and cell concentrations determined using the 50% endpoint method.
RESULTS
Members of the OPTI-FREE products (Express, Replenish, and Puremoist [Alcon, Fort Worth, TX]) demonstrated significantly higher percentages of antimicrobial activity compared with the renu Advanced Formula (Bausch + Lomb, Rochester, NY), Biotrue (Bausch + Lomb), Acuvue RevitaLens (Johnson & Johnson, Santa Ana, CA), and Lite products (Cooper Vision, Scottsville, NY) for four of the trophozoite strains tested.
CONCLUSIONS
Many of the popular MPS biocides maintain little or no antimicrobial activity against Acanthamoeba trophozoites, and the number of biocides in an MPS does not necessarily indicate its antimicrobial activity.Permalink : https://bibliotheque.helb-prigogine.be/opac_css/index.php?lvl=notice_display&id= [article]Exemplaires
Cote Support Localisation Section Disponibilité aucun exemplaire Drugs used in the treatment of anterior segment eye disease : anti-infectives and anti-glaucoma drugs / Lucy Titcomb in OPTOMETRY TODAY, vol.47, 21 (Novembre 2007)
[article]
in OPTOMETRY TODAY > vol.47, 21 (Novembre 2007) . - 30-39
Titre : Drugs used in the treatment of anterior segment eye disease : anti-infectives and anti-glaucoma drugs Type de document : article de périodique Auteurs : Lucy Titcomb, Auteur Article en page(s) : 30-39 Descripteurs (mots clés) : [Thésaurus Mesh]Glaucome
[Thésaurus Mesh]Pôle antérieur du bulbe oculaire
[Thésaurus Mesh]Solutions ophtalmiques
[Thésaurus Mesh]Traitement médicamenteuxPermalink : https://bibliotheque.helb-prigogine.be/opac_css/index.php?lvl=notice_display&id= [article]Exemplaires
Cote Support Localisation Section Disponibilité Périodique Erasme - périodiques Périodiques Disponible Drugs used in the treatment of dry eye syndrome, anti-inflammatory drugs and topical anti-allergy drugs / Elaine Mann in OPTOMETRY TODAY, vol.47, 23 (Novembre 2007)
PermalinkEffect of Autologous Serum Eye Drops on Corneal Haze after Corneal Cross-linking / Ana M. Roldan in OVS : Optometry & Vision Science, vol. 99, 02 (février 2022)
PermalinkGlaucoma patient preferences for video education on eye drop technique / Davis Scott A. in OVS : Optometry & Vision Science, vol. 96, 05 (Mai 2019)
PermalinkHeparin in the intraocular irrigating solution in pediatric cataract surgery / Huseyin Bayramlar in Journal of cataract refractive surgery, vol.30, 10 (Octobre 2004)
PermalinkHyaluronic Acid in Ophthalmology / Helmut Höh
PermalinkMeibomian Gland Changes in Open-angle Glaucoma Users Treated with Topical Medication / Diana Soriano in OVS : Optometry & Vision Science, vol. 98, 10 (Octobre 2021)
PermalinkA novel approach to helping people with glaucoma use their drops routinely / John McDonald in OVS : Optometry & Vision Science, vol. 96, 05 (Mai 2019)
PermalinkPermalinkOxymétazoline 0,1 % et ptose acquise / Jean-Pierre Lagacé in L'optométriste (UNIQUEMENT ACCESSIBLE EN PDF), vol. 44, 02 (Mars-avril 2022)
PermalinkPhentolamine Eye Drops Reverse Pharmacologically Induced Mydriasis in a Randomized Phase 2b Trial / Paul M. Karpecki in OVS : Optometry & Vision Science, vol. 98, 03 (Mars 2021)
PermalinkPréparations ophtalmiques / Marc Van Ooteghem
PermalinkPresbyopia treatment with eye drops : one drop and you regain the vision of a 20-years-old ? / Lena Petzold in Global contact, 95 (Septembre-décembre 2023)
PermalinkProphylaxie des infections conjonctivales du nouveau-né / Agence Française de Sécurité Sanitaire des Produits de Santé in Journal de pédiatrie et puériculture, vol.25, 2 (Avril 2012)
PermalinkQuantifying the Optical and Physical Consequences of Daily Cleaning on Conventional and Wavefront-guided Scleral Lenses / Sarah M. Horwitz in OVS : Optometry & Vision Science, vol. 97, 09 (Septembre 2020)
PermalinkSuccess of Masking 5% Povidone-Iodine Treatment: The Reducing Adenoviral Patient Infected Days Study / Meredith M. Whiteside in OVS : Optometry & Vision Science, vol. 98, 05 (Mai 2021)
PermalinkThe Effect of Cyclopentolate on Ocular Biometric Components / Hassan Hashemi in OVS : Optometry & Vision Science, vol. 97, 06 (Juin 2020)
PermalinkThe scope and options on use of “entry level ophthalmic drugs” by UK-based optometrists / Michaël Doughty in OPTOMETRY TODAY, vol.47, 8 (Avril 2007)
PermalinkThe Use of Autologous Serum Eye Drops after Epithelium-off Corneal Collagen Crosslinking / Ahmet Kirgiz in OVS : Optometry & Vision Science, vol. 97,04 (Avril 2020)
PermalinkTraitement du glaucome et observance des patients: les implants à la rescousse [partie I] / Jean-Pierre Lagacé in L'optométriste (UNIQUEMENT ACCESSIBLE EN PDF), vol. 44, 03 (Mai-juin 2022)
PermalinkTraitement des glaucomes : diminuer la pression pour stabiliser la maladie et surveiller à vie / Elisa Bluwol in La revue du praticien, vol.66, 5 (Mai 2016)
PermalinkTreatment of Myasthenic Ptosis with Topical Ocular Oxymetazoline / Jeffrey Cooper in OVS : Optometry & Vision Science, vol. 98, 11 (Novembre 2021)
PermalinkValidation of a More Reliable Method of Eye Drop Self-Administration / Thomas F. Freddo in OVS : Optometry & Vision Science, vol. 97, 07 (Juillet 2020)
Permalink